Characteristics and Outcome of ROS1-Positive Non–Small Cell Lung Cancer Patients in Routine Clinical Practice

ROS1-rearranged NSCLC is classified as a distinct molecular subset of NSCLC with a therapeutic target. ROS1 rearrangement is most often identified in never-smokers with adenocarcinoma and EGFR and ALK receptor tyrosine kinase gene (ALK) wild type. Treatment with tyrosine kinase inhibitors (TKIs), wh...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of thoracic oncology 2018-09, Vol.13 (9), p.1373-1382
Hauptverfasser:	Park, Sehhoon, Ahn, Beung-Chul, Lim, Sung Won, Sun, Jong-Mu, Kim, Hye Ryun, Hong, Min Hee, Lee, Se-Hoon, Ahn, Jin Seok, Park, Keunchil, Choi, Yoon La, Cho, Byoung Chul, Ahn, Myung-Ju
Format:	Artikel
Sprache:	eng
Schlagworte:	Carcinoma Crizotinib Non–small cell lung cancer Pemetrexed ROS1
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!